Table 2.
Characteristics among HIV positive participants (n = 721).
| Characteristics | n (%) |
|---|---|
| ART | |
| Currently on ART | 652 (90.4%) |
| Not on ART | 69 (9.6%) |
| ART Duration (years) | |
| <1 | 74 (10.2%) |
| 1–4 | 300 (41.6%) |
| 5–9 | 196 (27.2%) |
| 10+ | 77 (10.8%) |
| Missing | 74 (10.2%) |
| Viral Load (VL) | |
| Undetectable VL | 451 (62.6%) |
| Detectable VL | 34 (4.7%) |
| Missing | 236 (32.7%) |
| CD4+T cells (cells/mm3) | |
| <200 | 39 (5.4%) |
| 200–499 | 212 (29.4%) |
| ≥500 | 222 (30.8%) |
| Missing | 248 (34.4%) |
ART: Anti-retroviral therapy, CD4+T: cluster of differentiation CD4 lymphocytes.